Given its role as a SDH interaction partner and mitochondrial booster, CART may be suitable for treatment of some debilitating diseases, including mood disorders (MDD), obesity/diabetes, and neurodegenerative diseases. The gene discussed is CARTPT; the disease is major depressive disorder.